Answer
It is not easy to get a clear picture of the current situation and its interrelationships, given the various factors and causes involved. Increasingly, the competent federal authorities are finding that relevant medicines are disappearing from the market or that companies offering generic medicines are not marketing their products in Switzerland. Drug shortages are increasing both in Switzerland and worldwide, and the economic impact of such shortages on Switzerland is also increasing. Supply disruptions create significant additional work for all parties involved, resulting in higher costs. In addition, switching to a new drug or the lack of a drug can have a significant impact on patient therapy.